These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 3073870

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Treatment of chronic hepatitis B and C with alpha interferon].
    Hess G.
    Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130
    [No Abstract] [Full Text] [Related]

  • 26. Natural history and therapy of chronic hepatitis B virus infection.
    Alexander GJ, Williams R.
    Am J Med; 1988 Aug 29; 85(2A):143-6. PubMed ID: 3044078
    [Abstract] [Full Text] [Related]

  • 27. Effect of 28 consecutive days lymphoblastoid interferon (alpha-IFN) administration on hepatitis B virus related chronic liver disease.
    Franco A, Barnaba V, Levrero M, Ruberti G, Van Dyke A, Bonavita MS, Balsano F.
    J Hepatol; 1986 Aug 29; 3 Suppl 2():S239-43. PubMed ID: 3298412
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.
    Lam KC, Lai CL, Trepo C, Wu PC.
    N Engl J Med; 1981 Feb 12; 304(7):380-6. PubMed ID: 7005678
    [Abstract] [Full Text] [Related]

  • 32. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
    Alexander GJ, Brahm J, Fagan EA, Smith HM, Daniels HM, Eddleston AL, Williams R.
    Lancet; 1987 Jul 11; 2(8550):66-9. PubMed ID: 2885573
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immunological markers in patients with different forms of viral hepatitis B treated by "conventional" therapy or with HuIFN alpha.
    Stancek D, Janota S, Blaskovicová H, Hajnická V, Laktis K, Sudová J, Cvopová A, Klement C.
    Acta Virol; 1990 Sep 11; 34(5):467-76. PubMed ID: 1981457
    [Abstract] [Full Text] [Related]

  • 39. A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.
    Barbara L, Mazzella G, Baraldini M, Gasbarrini G, Giungi F, Malavolti M, Mastroroberto L, Miglio F, Roda E, Raise E.
    J Hepatol; 1986 Sep 11; 3 Suppl 2():S235-8. PubMed ID: 3298411
    [No Abstract] [Full Text] [Related]

  • 40. Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy.
    Hirai N, Shimizu M, Morioka T, Hinoue Y, Tanaka N, Kobayashi K, Hattori N, Hashimoto T.
    Liver; 1988 Jun 11; 8(3):138-45. PubMed ID: 3393063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.